Vaxcyte
PCVX
PCVX
314 hedge funds and large institutions have $5.85B invested in Vaxcyte in 2025 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 129 increasing their positions, 97 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 322 → 314 (-8)
42% less funds holding in top 10
Funds holding in top 10: 12 → 7 (-5)
49% less capital invested
Capital invested by funds: $11.5B → $5.85B (-$5.68B)
Holders
314
Holding in Top 10
7
Calls
$14.1M
Puts
$9.79M
Top Buyers
| 1 | +$280M | |
| 2 | +$158M | |
| 3 | +$95.2M | |
| 4 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$69M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$60M |
Top Sellers
| 1 | -$158M | |
| 2 | -$80.9M | |
| 3 | -$46.3M | |
| 4 |
BlackRock
New York
|
-$42.1M |
| 5 |
FAM
Fred Alger Management
New York
|
-$40M |